Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.76 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
9.25 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.25 | 14514962 11752688 15322242 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.99 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.51 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.51 | 17638652 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
7.06 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
7.06 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.57 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.59 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
9.12 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
9.12 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.06 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.25 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.58 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.12 | 17286800 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.35 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.18 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.00 | 11985600 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.48 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
3.85 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
3.85 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
3.85 | 16110121 15136595 16557594 19217205 18357371 18608205 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
3.85 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
3.85 | 17534123 17651959 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
3.85 | 19288272 11161223 18997820 18815881 19487384 16202921 17261762 19410462 19103187 19221464 21152245 19189212 19200415 18351453 17049068 15565566 19066611 19115204 18984771 20135344 20005174 15668708 18425577 19189210 16818667 19142967 20859285 20544844 20065188 19084267 20390343 17893378 16873071 21138602 19289846 18855134 17242785 19011961 17440819 18629630 18821012 19244106 19059307 16273361 19155303 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.85 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.89 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.56 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.56 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.68 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
6.75 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
6.75 | 17045692 17088986 16799960 18930000 16332177 17971768 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
6.75 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
6.75 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.18 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.78 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.07 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.80 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.80 | 16757204 16280240 17066447 18986760 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
7.80 | 16227395 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.75 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.57 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.66 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.82 | 20889678 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.15 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.30 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.99 | 16510598 17169374 17725105 17172411 16340194 18772588 15001691 17287894 17016597 17018589 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.99 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.71 | 18509181 16331619 16524972 14970324 16303861 18949393 20501625 17255274 17695437 17094418 18383874 17594712 17401013 17016601 15148649 18448328 17454858 16282729 18802399 18288408 16391804 15289873 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.71 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.84 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.79 | 12039119 9562676 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.79 | 20055451 10048152 15322242 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.37 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.99 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.54 | 19031437 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.29 | 20191521 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.89 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
9.46 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
9.46 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.47 | 15619225 19739265 10663392 19085960 19420014 17522070 16485898 17906064 11529661 15968718 18713872 16227642 12392966 16109766 11743745 14725611 16393943 16177239 11739529 11461765 12153990 10915739 12540782 12705907 10774834 18071297 14550746 19416960 19370779 11421492 17562736 11287661 19164858 12958197 19923254 16081117 2444490 11834606 12594235 16781746 14986274 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
6.47 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.47 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.32 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
MESH:D004487 |
Edema |
|
resveratrol |
7.33 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.33 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.12 | 16714409 18230668 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
9.80 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.80 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.13 | 20544844 16202921 17893378 19155303 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
9.59 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.59 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
5.02 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.42 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
7.42 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
7.42 | 15173087 16785472 16337965 17638652 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
3.30 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.31 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.72 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.38 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.12 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.89 | 16983495 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.92 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.32 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.48 | 18337622 15102660 15162350 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.67 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.67 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.07 | 15340226 16120746 12621046 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.37 | 16876885 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 18606429 8697196 16354765 15340226 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.81 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
4.14 | 17188708 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
4.18 | 16873680 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.95 | 18670907 18850075 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.43 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.82 | 17600658 |
MESH:D007249 |
Inflammation |
|
resveratrol |
8.73 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.73 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.73 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.76 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.38 | 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.27 | 12587719 15629191 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
7.90 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.90 | 18625569 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.25 | 9562676 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.66 | 16087638 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.25 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.77 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.32 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.32 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.66 | 11587558 16610002 19014921 12587719 19460945 16611625 19784758 12969438 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.37 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.77 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
14.77 | 17045692 15113037 16603448 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
14.77 | 19812893 20405173 19073162 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
14.77 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.77 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.19 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.24 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.95 | 6695378 18816296 20869020 18569708 20064080 20464547 20135361 18520028 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
4.95 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.95 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.95 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.99 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.05 | 17352296 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.45 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.99 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
10.66 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
10.66 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
6.46 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.46 | 19196723 14580682 16827153 11731420 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.76 | 19453300 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.51 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.51 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.38 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.74 | 19513568 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.52 | 17112576 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.89 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
8.89 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.47 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.56 | 17049120 17164350 16490592 16267019 17935668 14749477 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
5.06 | 17962980 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
3.08 | 16456233 16525036 17015251 17188708 17125593 16317513 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
9.39 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.39 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.95 | 17322642 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.59 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.55 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.28 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
5.28 | 16928823 18600527 18239605 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
4.17 | 8985016 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.22 | 19189210 19200415 19196722 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
10.13 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.13 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.75 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
8.75 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.55 | 17929310 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.53 | 16436463 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.41 | 17513867 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.18 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
3.16 | 16525653 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.50 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.71 | 19003803 16500647 15113037 16929163 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
17.48 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
17.48 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
17.48 | 11896295 11222880 11399792 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.35 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.86 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.86 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
1.86 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
1.86 | 17804756 16731767 17675339 15767336 17636462 17718901 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.86 | 15067354 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.47 | 17410198 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.98 | 10548101 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.14 | 15538739 16160472 18722050 18286688 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.89 | 17352296 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.80 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.33 | 16314181 17520802 16317513 15827377 17058453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.80 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
9.80 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.80 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.51 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.23 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.45 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.45 | 16951190 17522103 19015929 16424979 18396642 17498489 15786421 18567086 17172411 19084572 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.61 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.18 | 16684133 16045194 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.20 | 9562676 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
10.43 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
10.43 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.16 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.16 | 8653321 17572228 16712894 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.12 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
10.05 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
10.05 | 17473185 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.23 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.30 | 17044934 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.48 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |